Table 1 Baseline characteristics of patients included in the PEARL study
Total population (N = 448) | oxLDL not studied (N = 281) | oxLDL studied (N = 167) | p | |
|---|---|---|---|---|
Female gender (%) | 354 (79) | 224 (79.7) | 130 (77.8) | 0.638 |
Age (years) | 55 [44–67] | 58 [44–68] | 52 [43–65] | 0.08 |
Disease duration (months) | 5 [3–8] | 5 [3–8] | 6 [4–9] | 0.004 |
DAS28 | 4.4 [3.3–5.5] | 4.1 [3.3–5.5] | 4.7 [3.5–5.7] | 0.060 |
SDAI | 18 [9.6–29.2] | 17 [8.8–29] | 19.2 [10.4–29.5] | 0.183 |
HUPI | 7 [4.5–10] | 7 [4–10] | 8 [5–9.5] | 0.174 |
HAQ | 0.875 | 0.875 | 1 | 0.059 |
[0.5–1.625] | [0.375–1.625] | [0.625–1.625] | ||
RF (%) | 54 | 57 | 48 | 0.054 |
ACPA (%) | 50 | 53 | 46 | 0.175 |
UA (%) | 28 | 26 | 30 | 0.297 |
Smoking (%) | 21.4 | 20 | 24.2 | 0.36 |
Statins use (%) | 10.7 | 12 | 9 | 0.361 |
BMI p50 [IQR] | 26.1 [23.4–29] | 25.9 [22.9–29] | 26.3 [23.9–29.1] | 0.171 |